Key stats
About Direxion Daily Healthcare Bull 3X Shares
Home page
Inception date
Jun 15, 2011
Structure
Open-Ended Fund
Replication method
Synthetic
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Rafferty Asset Management LLC
Distributor
Foreside Fund Services LLC
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare nameslike J&J, Pfizer, and Merckin the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks71.47%
Health Technology57.83%
Health Services9.64%
Distribution Services2.69%
Retail Trade1.20%
Commercial Services0.11%
Bonds, Cash & Other28.53%
Cash28.53%
Stock breakdown by region
North America97.23%
Europe2.77%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CURE invests in stocks. The fund's major sectors are Health Technology, with 57.83% stocks, and Health Services, with 9.64% of the basket. The assets are mostly located in the North America region.
CURE last dividends amounted to 0.35 USD. The quarter before, the issuer paid 0.12 USD in dividends, which shows a 66.42% increase.
CURE assets under management is 135.87 M USD. It's risen 26.67% over the last month.
CURE fund flows account for −14.95 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, CURE pays dividends to its holders with the dividend yield of 1.33%. The last dividend (Apr 1, 2025) amounted to 0.35 USD. The dividends are paid quarterly.
CURE shares are issued by Rafferty Asset Management LLC under the brand Direxion. The ETF was launched on Jun 15, 2011, and its management style is Passive.
CURE expense ratio is 0.93% meaning you'd have to pay 0.93% of your investment to help manage the fund.
CURE follows the S&P Health Care Select Sector. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CURE invests in stocks.
CURE price has risen by 5.44% over the last month, and its yearly performance shows a −32.78% decrease. See more dynamics on CURE price chart.
NAV returns, another gauge of an ETF dynamics, showed a −22.38% decrease in three-month performance and has decreased by −31.61% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −22.38% decrease in three-month performance and has decreased by −31.61% in a year.
CURE trades at a premium (0.02%) meaning the ETF is trading at a higher price than the calculated NAV.